HealthJun 05, 2026
Imunon raises $10.0M (Jun 2026)
$10.0M
10 Million DollarsGenerated social card
Headline
Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial - HarianBasis.co
About
Imunon is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is currently conducting a trial for ovarian cancer, which is a significant area of need in oncology. This funding will support their efforts to advance their clinical programs.
Article summary
Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial HarianBasis.co
Investors
Related rounds
| Jun 05, 2026 | Joyvié Health | $950K | — | — |
| Jun 04, 2026 | Novellia | $18.0M | Series A | United States |
| Jun 03, 2026 | CrossBridge Bio | $300.0M | — | United States |
| Jun 03, 2026 | Apogee Therapeutics, Inc. | $1.30B | — | — |